Tag Archives: AXIM

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

SeeThruEquity RSHO Raúl Elizalde

SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00

SAN DIEGO, Calif., May 17, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received coverage initiation from SeeThruEquity, a leading independent equity research firm focused on smallcap and microcap public companies, with a price target of $17.00.

Axim Biotech - MedChew Rx

AXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing Gum

NEW YORK, May 02, 2017 /Weed Wire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company’s product development partner Quay Pharmaceuticals Ltd. (“Quay Pharma”) has obtained the relevant licenses from the British Home Office to import and work with the controlled drugs that are required to continue the development of AXIM’s MedChew Rx® pharmaceutical chewing gum’s family of products.

Marijuana Index Drops 2% as Canadian Stocks Dip With Federal Uncertainty

Marijuana Index Drops 2% as Canadian Stocks Dip With Federal Uncertainty

The North American Marijuana Index, a stock index that tracks the top performing cannabis stocks in the United States and Canada, decreased 2% in March as losses in Canada overtook modest gains in the U.S.

https://marijuanaindex.com/stock-quotes/north-american-marijuana-index/

A Survey Of The North American Marijuana Index – Part One

In this survey we will be reviewing the stocks that make up the North American Marijuana Index. In Part 1, we’ll look at Canopy Growth Corp. (OTCPK:TWMJF), GW pharmaceuticals (NASDAQ:GWPH), Axim Biotechnologies Inc. (OTCQB:AXIM), and United Cannabis Corp. (OTCQB:CNAB).

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol

SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

NEW YORK, March 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has retained the services of Ora®, Inc.,

Axim Biotech - MedChew Rx

AXIM Biotech Enters IBS Clinical Trial for Canchew CBD Chewing Gum

NEW YORK, Jan. 18, 2017 /Weed Wire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has entered clinical trials on treating irritable bowel syndrome (IBS) with the Company’s CanChew Plus® cannabidiol (CBD) gum at Wageningen University in the Netherlands.

SeeThruEquity RSHO Raúl Elizalde

Forbes Features Medical Marijuana, Inc. in Article Citing Company’s Sales Data After Starting CBD Market ‘That Could Grow 700% by 2020’

SAN DIEGO, Dec. 14, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes article focused on the current cannabidiol (CBD) market size and anticipated massive growth.

SeeThruEquity RSHO Raúl Elizalde

Medical Marijuana, Inc.’s Investment Axim(R) Biotech Files IP Application on Proprietary Method to Extract High-Purity THC

SAN DIEGO, Nov. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC PINK: AXIM) has filed an IP application with the World Intellectual Property Organization.

bq7xic1ceaae77r-pnglarge

New U.S. Patent Allowance Granted to AXIM® Biotech for Use of All Cannabinoids in Its Controlled-Release Chewing Gum Products

NEW YORK, Nov. 16, 2016 /Weed Wire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM), a world leader in hemp cannabinoid research and development, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Application Serial Number 9,433,601.

Axim Biotech - MedChew Rx

AXIM Biotech Announces Launch of Clinical Trials on MedChew RX™ and Development of Pharmaceutical-Grade Cannabis Chewing Gum

SAN DIEGO, Aug. 11, 2015 /Weed Wire/ — AXIM Biotechnologies, Inc. (OTC: AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical, nutraceutical, food and cosmetic products – all derived from industrial hemp.

Conference

Chicago Cannabis Conference Spotlights CBD, Tech Innovations

This year’s annual My Compassion Cannabis Conference in Chicago brought together advocates, vendors and prospective medical marijuana patients during a three-day event focused on education and networking.

MJNA and AXIM

Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies

SAN DIEGO, June 30, 2015 /Weed Wire/ — Medical Marijuana, Inc. (OTC Pink:MJNA) would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies(AXIM), a cutting-edge biotechnology innovator.


Top